These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8222476)

  • 1. Alterations in theophylline metabolism during the first year of life.
    Kraus DM; Fischer JH; Reitz SJ; Kecskes SA; Yeh TF; McCulloch KM; Tung EC; Cwik MJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):351-9. PubMed ID: 8222476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
    Le Guennec JC; Billon B; Paré C
    Pediatrics; 1985 Nov; 76(5):834-40. PubMed ID: 4058995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life.
    Lönnerholm G; Lindström B; Paalzow L; Sedin G
    Eur J Clin Pharmacol; 1983; 24(3):371-4. PubMed ID: 6861850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH; Sollie FA; Sauter R; Steinijans VW
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturational changes of theophylline pharmacokinetics in preterm infants.
    Dothey CI; Tserng KY; Kaw S; King KC
    Clin Pharmacol Ther; 1989 May; 45(5):461-8. PubMed ID: 2721102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental aspects of theophylline metabolism in premature infants.
    Tserng KY; Takieddine FN; King KC
    Clin Pharmacol Ther; 1983 Apr; 33(4):522-8. PubMed ID: 6831832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
    Ginsberg G; Hattis D; Russ A; Sonawane B
    J Toxicol Environ Health A; 2004 Feb; 67(4):297-329. PubMed ID: 14713563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on patterns of theophylline metabolism.
    Grygiel JJ; Birkett DJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):456-62. PubMed ID: 7408405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
    Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline metabolism in premature infants.
    Tserng KY; King KC; Takieddine FN
    Clin Pharmacol Ther; 1981 May; 29(5):594-600. PubMed ID: 7214789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal theophylline intoxication: pharmacokinetics and clinical evaluation.
    Skopnik H; Bergt U; Heimann G
    Eur J Pediatr; 1992 Mar; 151(3):221-4. PubMed ID: 1601017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline metabolism during the first month of life and development.
    Bonati M; Latini R; Marra G; Assael BM; Parini R
    Pediatr Res; 1981 Apr; 15(4 Pt 1):304-8. PubMed ID: 7220153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients.
    Tateishi T; Asoh M; Yamaguchi A; Yoda T; Okano YJ; Koitabashi Y; Kobayashi S
    Pediatr Res; 1999 Jan; 45(1):66-70. PubMed ID: 9890610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline and caffeine disposition in the neonatal piglet.
    Kearns GL; Hill DE; Tumbelson ME
    Dev Pharmacol Ther; 1986; 9(6):389-401. PubMed ID: 3816492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans.
    Rasmussen BB; Brøsen K
    Br J Clin Pharmacol; 1997 Mar; 43(3):253-8. PubMed ID: 9088579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline pharmacokinetics in patients with bronchopulmonary dysplasia.
    Nahata MC; Serafini D; Edwards R
    J Clin Pharm Ther; 1989 Jun; 14(3):225-9. PubMed ID: 2760121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline pharmacokinetics in normal elderly subjects.
    Shin SG; Juan D; Rammohan M
    Clin Pharmacol Ther; 1988 Nov; 44(5):522-30. PubMed ID: 3180633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The population pharmacokinetics of theophylline in neonates and young infants.
    Moore ES; Faix RG; Banagale RC; Grasela TH
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):47-66. PubMed ID: 2715932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.